The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activity of VERU-111, an novel oral α and β tubulin inhibitor, against paclitaxel sensitive and resistant prostate cancer.
 
Robert H. Getzenberg
Employment - GTx; Veru
Stock and Other Ownership Interests - GTx; Veru
 
James T. Dalton
Patents, Royalties, Other Intellectual Property - GTx; Veru
 
Duane D. Miller
Patents, Royalties, Other Intellectual Property - GTx; Veru
 
Mitchell S. Steiner
Employment - Aspen Park Pharmaceuticals; OPKO Health; Veru
Leadership - Aspen Park Pharmaceuticals; OPKO Diagnostics; Veru
Stock and Other Ownership Interests - Aspen Park Pharmaceuticals; Veru